We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03064074
Recruitment Status : Completed
First Posted : February 24, 2017
Last Update Posted : July 6, 2022
Genzyme, a Sanofi Company
Oregon Health and Science University
Information provided by (Responsible Party):
Brendan Lee, Baylor College of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 4, 2022
Actual Study Completion Date : July 4, 2022